FOXO3 and metabolic dysfunction-associated steatotic liver disease: As one of the numerous potential targets of miR-122-5p, FOXO3 has been reported to be implicated in the regulation of lipid metabolism, inflammation response, and fibrosis in the development of NAFLD (Dong, 2017).